High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma

被引:58
|
作者
Yoshimoto, T.
Matsuura, K.
Karnan, S.
Tagawa, H.
Nakada, C.
Tanigawa, M.
Tsukamoto, Y.
Uchida, T.
Kashima, K.
Akizuki, S.
Takeuchi, I.
Sato, F.
Mimata, H.
Seto, M.
Moriyama, M.
机构
[1] Oita Univ, Dept Mol Pathol, Fac Med, Oita 87011, Japan
[2] Oita Univ, Dept Urol, Fac Med, Oita 87011, Japan
[3] Aichi Canc Ctr, Div Mol Med, Nagoya, Aichi 464, Japan
[4] Oita Univ, Div Biomol Med & Med Imaging, Oita 87011, Japan
[5] Oita Univ Hosp, Pathol Ctr, Oita, Japan
[6] Shin Beppu Hosp, Dept Pathol, Oita, Japan
[7] Mie Univ, Grad Sch Engn, Div Comp Sci, Tsu, Mie, Japan
来源
JOURNAL OF PATHOLOGY | 2007年 / 213卷 / 04期
关键词
renal cell carcinoma; clear cell carcinoma; array CGH; gene expression; oligonucleotide microarray;
D O I
10.1002/path.2239
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We analysed chromosomal copy number aberrations (CNAs) in renal cell carcinomas by array-based comparative genomic hybridization, using a genome-wide scanning array with 2304 BAC and PAC clones covering the whole human genome at a resolution of roughly 1.3 Mb. A total of 30 samples of renal cell carcinoma were analysed, including 26 cases of clear cell carcinoma (CCC) and four cases of chromophobe renal cell carcinoma (ChCC). In CCCs, gains of chromosomes 5q33.1-qter (58%), 7q11.22-q35 (35%) and 16p12.3-p13.12 (19%), and losses of chromosomes 3p25.1-p25.3 (77%), 3p21.31-p22.3 (81%), 3p14.1-p14.2 (77%), 8p23.3 (31%), 9q21.13-qter (19%) and 14q32.32-qter (38%) were detected. On the other hand, the patterns of CNAs differed markedly between CCCs and ChCCs. Next, we examined the correlation of CNAs with expression profiles in the same tumour samples in 22/26 cases of CCC, using oligonucleotide microarray. We extracted genes that were differentially expressed between cases with and without CNAs, and found that significantly more up-regulated genes were localized on chromosomes 5 and 7, where recurrent genomic gains have been detected. Conversely, significantly more down-regulated genes were localized on chromosomes 14 and 3, where recurrent genomic losses have been detected. These results revealed that CNAs were correlated with deregulation of gene expression in CCCs. Furthermore, we compared the patterns of genomic imbalance with histopathological features, and found that loss of 14q appeared to be a specific and additional genetic abnormality in high-grade CCC. When we compared the expression profiles of low-grade CCCs with those of high-grade CCCs, differentially down-regulated genes tended to be localized on chromosomes 14 and 9. Thus, it is suggested that copy number loss at 14q in high-grade CCC may be involved in the down-regulation of genes located in this region. Copyright (c) 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
引用
收藏
页码:392 / 401
页数:10
相关论文
共 50 条
  • [31] High-resolution Analysis of DNA Copy Number Alterations in Chinese Patients with Isolated Secundum Atrial Septal Defect
    Zhao Wei
    Shen Botao
    Zheng Yang
    Li Shibo
    Zheng Yang
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (16) : C55 - C55
  • [32] Stratification of clear cell renal cell carcinoma (ccRCC) genomes by gene-directed copy number alteration (CNA) analysis
    Thiesen, H. -J.
    Steinbeck, F.
    Maruschke, M.
    Koczan, D.
    Ziems, B.
    Hakenberg, O. W.
    PLOS ONE, 2017, 12 (05):
  • [33] Somatic Copy Number Alterations and Associated Genes in Clear-Cell Renal-Cell Carcinoma in Brazilian Patients
    Fernandes, Flavia Goncalves
    Silveira, Henrique Cesar Santejo
    Junior, Joao Neif Antonio
    da Silveira, Rosana Antunes
    Zucca, Luis Eduardo
    Carcano, Flavio Mavignier
    Sanches, Andre Octavio Nicolau
    Neder, Luciano
    Scapulatempo-Neto, Cristovam
    Serrano, Sergio Vicente
    Jonasch, Eric
    Reis, Rui Manuel
    Evangelista, Adriane Feijo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (05) : 1 - 14
  • [34] High-resolution analysis of DNA copy number alterations in colorectal cancer by array-based comparative genomic hybridization
    Nakao, K
    Mehta, KR
    Moore, DH
    Jain, AN
    Lafuente, A
    Wiencke, JW
    Terdiman, JP
    Waldman, FM
    CARCINOGENESIS, 2004, 25 (08) : 1345 - 1357
  • [35] Genomic Copy Number Alterations in Renal Cell Carcinoma with Sarcomatoid Features
    Ito, Timothy
    Pei, Jianming
    Dulaimi, Essel
    Menges, Craig
    Abbosh, Philip H.
    Smaldone, Marc C.
    Chen, David Y. T.
    Greenberg, Richard E.
    Kutikov, Alexander
    Viterbo, Rosalia
    Uzzo, Robert G.
    Testa, Joseph R.
    JOURNAL OF UROLOGY, 2016, 195 (04): : 852 - 858
  • [36] Genomic copy number alterations in cancer: high-resolution analysis of the NCI-60 panel
    Rico, D.
    Earl, J.
    Diaz-Uriarte, R.
    Rueda, O. M.
    Marenne, G.
    Pita, G.
    NEW BIOTECHNOLOGY, 2010, 27 : S81 - S81
  • [37] Relevance of arm somatic copy number alterations for oncologic outcomes and tumor immune microenvironment in clear cell renal cell carcinoma
    Xiong, Ying
    Qi, Yu
    Bai, Qi
    Xia, Yu
    Liu, Li
    Guo, Jianming
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (22)
  • [38] Analysis of alterations in the VHL gene and clinical significance in renal clear cell carcinoma cell type
    Alves, M.
    Costa, W.
    Silva, F.
    Carraro, D.
    Cunha, I.
    Zequi, S.
    Guimaraes, G.
    Soares, F.
    Rocha, R.
    VIRCHOWS ARCHIV, 2013, 463 (02) : 124 - 124
  • [39] Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer
    Tsukamoto, Y.
    Uchida, T.
    Kaman, S.
    Noguchi, T.
    Nguyen, L. T.
    Tanigawa, M.
    Takeuchi, I.
    Matsuura, K.
    Hijiya, N.
    Nakada, C.
    Kishida, T.
    Kawahara, K.
    Ito, H.
    Murakami, K.
    Fujioka, T.
    Seto, M.
    Moriyama, M.
    JOURNAL OF PATHOLOGY, 2008, 216 (04): : 471 - 482
  • [40] Use of microgenomic technology for analysis of alterations in DNA copy number and gene expression in malignant melanoma
    Trent, JM
    Bittner, MH
    Zhang, J
    Wiltshire, R
    Ray, M
    Su, Y
    Gracia, E
    Meltzer, P
    DeRisi, J
    Penland, L
    Brown, P
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 107 : 33 - 40